News

As a part of the agreement, TOLMAR will supply up to nine currently approved and marketed products while Global Pharmaceuticals, Impax’s generics division, will commercialize these products following

The submission is based on Phase 3 AFFIRM trial of enzalutamide in post-chemotherapy prostate cancer patients in which seizure was reported in less than 1% of enzalutamide-treated patients.

Under the multi-year relationship with Eli Lilly and Company, PrimeraDx will develop diagnostic products in support of multiple clinical development programs for novel therapeutics. PrimeraDx president and CEO

Caris Target Now has been updated to offer both on- and off-Compendium therapeutic associations for all solid tumours, across a wide range of evidence. The product identifies the

The OneSource Scientific IT Services include scientific Applications Services, computer systems validation, lab computing services and Scientific Data Services. The new solutions assist customers in minimising the gap

NSI-189, a proprietary new chemical entity, stimulates new neuron growth in the hippocampus, a region of the brain believed to be implicated in MDD as well as other

Under the partnership, DASA’s physicians will have access to Pathway’s Cardiac Health Insight and Pathway Fit genetic tests which will bring additional personalized care to more than 180

EPS is offering analytical services, such as nuclear magnetic resonance spectroscopy (NMR) and liquid chromatography-mass spectrometry (LC-MS), and microbiological testing such as comprehensive drug resistance profiling and biofilm

Based on its market analysis, Nouveau has begun the production of four products that are commonly used by older adults. Nouveau Life CEO Melissa Walker said, "The CAGR